Your email has been successfully added to our mailing list.

×
0 -0.00420168067226882 -0.00420168067226882 -0.00420168067226882 -0.00420168067226882 -0.00420168067226882 0.00840336134453782 0.0294117647058825
Stock impact report

Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Delayed-release Tablets in the United States

Endo International plc - Ordinary Shares (ENDP) 
Last endo international plc - ordinary shares earnings: 2/26 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.endo.com/newsroom/news-releases
Company Research Source: PR Newswire
DUBLIN, Sept. 3, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical (Par), has begun shipping an authorized generic version of Merck's Noxafil® (posaconazole) delayed-release tablets, 100 mg. Endo's subsidiary, Endo Ventures Limited, recently entered into an exclusive U.S. supply and distribution agreement with a subsidiary of Merck & Co., Inc., of Kenilworth, N.J. allowing Par to launch and distribute an authorized generic version of the product.  The agreement also includes rights to posaconazole 40mg/mL oral suspension which Par intends to launch in the coming months."Par is pleased to provide patients and providers with access to a lower-cost treatment through our launch of the authorized generic version of Noxafil®," said Domenic Ciarico, Executive Vice President & Chief Commercial Officer, Sterile & Generics at Endo. "We are proud to add this differentiated product to our portfolio."Noxafil® is a Show less Read more
Impact Snapshot
Event Time:
ENDP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ENDP alerts
Opt-in for
ENDP alerts

from News Quantified
Opt-in for
ENDP alerts

from News Quantified